Molecular Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Chemical and Biological Aspects of Inflammation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sengupta, K.
Right arrow Articles by Banerjee, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sengupta, K.
Right arrow Articles by Banerjee, S. K.
Molecular Cancer Research 2:150-158 (2004)
© 2004 American Association for Cancer Research


Angiogenesis, Metastasis, and Cellular Microenvironment

Thombospondin-1 Disrupts Estrogen-Induced Endothelial Cell Proliferation and Migration and Its Expression Is Suppressed by Estradiol1

Krishanu Sengupta, Snigdha Banerjee, Neela K. Saxena and Sushanta K. Banerjee

Cancer Research Unit, VA Medical Center, Kansas City, MO and Division of Hematology and Oncology, Department of Medicine, University of Kansas Medical Center, Kansas City, KS

Requests for reprints: Sushanta K. Banerjee, Cancer Research Unit, Research Division 151, VA Medical Center, 4801 Linwood Boulevard, Kansas City, MO 64128. Phone: (816) 861-4700x7057; Fax: (816) 922-3320. E-mail: sbanerjee2{at}kumc.edu

The natural hormone 17ß-estradiol (17ß-E2) is known to induce tumor angiogenesis in various target organs by activating positive regulators of angiogenesis. In this study, we show for the first time that in human umbilical vein endothelial cells (HUVECs), 17ß-E2 transiently down-regulates the expression and secretion of a potent negative regulator of angiogenesis, thrombospondin-1 (TSP-1). This inhibitory effect of 17ß-E2 is mediated through nongenomic estrogen receptor (ER)/mitogen-activated protein kinase (MAPK)/extracellular-regulated kinase (ERK) 1/2 and c-Jun NH2-terminal kinase (JNK)/stress-activated protein kinase (SAPK) signaling pathways, because this effect can be abolished by a pure ER antagonist (ICI 182,780) and inhibitors of downstream signaling proteins of MAPK signaling cascades, including MAPK kinase 1/2 and ERK1/2 inhibitor and JNK/SAPK inhibitor. To understand the functional role(s) of TSP-1 during estradiol-induced angiogenesis, we examined the growth and migration of endothelial cells in different experimental environments. Using a recombinant protein, we show that increments of TSP-1 protein concentration in culture medium significantly reduce the migration and proliferation of HUVECs stimulated by 17ß-E2. Together, these studies suggest that TSP-1 can be considered an important negative factor in understanding the increased angiogenesis in response to estrogens.




This article has been cited by other articles:


Home page
Cancer Res.Home page
G. Dhar, S. Banerjee, K. Dhar, O. Tawfik, M. S. Mayo, P. J. VanVeldhuizen, and S. K. Banerjee
Gain of Oncogenic Function of p53 Mutants Induces Invasive Phenotypes in Human Breast Cancer Cells by Silencing CCN5/WISP-2
Cancer Res., June 15, 2008; 68(12): 4580 - 4587.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. H. Thomas, H. Wilson, A. Silvestri, and H. M. Fraser
Thrombospondin-1 Expression Is Increased during Follicular Atresia in the Primate Ovary
Endocrinology, January 1, 2008; 149(1): 185 - 192.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Dhar, S. Banerjee, G. Dhar, K. Sengupta, and S. K. Banerjee
Insulin-like Growth Factor-1 (IGF-1) Induces WISP-2/CCN5 via Multiple Molecular Cross-talks and Is Essential for Mitogenic Switch by IGF-1 Axis in Estrogen Receptor-Positive Breast Tumor Cells
Cancer Res., February 15, 2007; 67(4): 1520 - 1526.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. J Sarkar, K. Chaturvedi, C. P. Chen, and D. K Sarkar
Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors
J. Endocrinol., February 1, 2007; 192(2): 395 - 403.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P. A Orihuela, A. Parada-Bustamante, L. M Zuniga, and H. B Croxatto
Inositol triphosphate participates in an oestradiol nongenomic signalling pathway involved in accelerated oviductal transport in cycling rats.
J. Endocrinol., March 1, 2006; 188(3): 579 - 588.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. A. Ridnour, J. S. Isenberg, M. G. Espey, D. D. Thomas, D. D. Roberts, and D. A. Wink
Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1
PNAS, September 13, 2005; 102(37): 13147 - 13152.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Colombel, S. Filleur, P. Fournier, C. Merle, J. Guglielmi, A. Courtin, A. Degeorges, C. M. Serre, R. Bouvier, P. Clezardin, et al.
Androgens Repress the Expression of the Angiogenesis Inhibitor Thrombospondin-1 in Normal and Neoplastic Prostate
Cancer Res., January 1, 2005; 65(1): 300 - 308.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.